Pivotal bioVenture Partners Investment Advisor LLC
Venture CapitalPosition in PCVX — Vaxcyte, Inc.
CIK 1844645
SAN FRANCISCO, CA
Position in PCVX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$82,862,571
+$3,110,955 QoQ
Shares Held
1,425,470
+3.9% QoQ
Ownership
0.958%
of shares outstanding
% of Portfolio
26.92%
of 13F equity value
Holder Rank
#21
of 329 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Pivotal bioVenture Partners Investment Advisor LLC holds $291,774,212 across 12 Biotechnology names. PCVX ranks #1 (28.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCVX |
Vaxcyte, Inc.
This page
|
1,425,470 | $82,862,571 | |
| 2 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,265,283 | $33,175,720 | |
| 3 | TRVI |
Trevi Therapeutics, Inc.
|
1,742,672 | $32,500,832 | |
| 4 | AVLN |
Avalyn Pharma Inc.
|
966,792 | $31,826,792 | |
| 5 | EVMN |
Evommune, Inc.
|
1,926,943 | $25,609,072 | |
| 6 | MPLT |
MapLight Therapeutics, Inc.
|
611,446 | $21,914,224 | |
| 7 | OCS |
Oculis Holding AG
|
1,506,250 | $20,891,687 | |
| 8 | IMNM |
Immunome Inc.
|
732,512 | $15,521,929 |
All Filings in PCVX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $82,862,571 | 1,425,470 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $79,751,616 | 1,372,425 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $63,323,689 | 1,372,425 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $49,434,748 | 1,372,425 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $42,429,613 | 1,305,125 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $26,837,315 | 710,734 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $57,615,851 | 703,834 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $73,080,121 | 639,539 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $59,882,148 | 793,036 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $54,172,289 | 793,036 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $49,802,660 | 793,036 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $40,428,975 | 793,036 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $39,604,217 | 793,036 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $25,975,101 | 693,039 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $33,231,220 | 693,039 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $18,624,936 | 776,039 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $18,107,932 | 832,166 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $26,842,362 | 1,111,485 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $26,442,228 | 1,111,485 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $35,655,530 | 1,405,421 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $31,636,026 | 1,405,421 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $27,757,064 | 1,405,421 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $59,064,312 | 2,222,970 | Shares | Defined | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||